Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
This study is currently recruiting participants.
Verified March 2013 by Massachusetts General Hospital
Sponsor:
Massachusetts General Hospital
Information provided by (Responsible Party):
Jason Faris, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01466036
First received: October 24, 2011
Last updated: March 13, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |